Transitioning from a vial to a prefilled syringe can provide a competitive advantage and is often a prerequisite for integration with autoinjectors and other drug delivery devices. However, the transition introduces new considerations for container closure selection, formulation compatibility, stability testing, and regulatory requirements.
This whitepaper walks through the vial-to-syringe tech transfer process, outlining the key decisions and testing requirements to help sponsors prepare for commercialization.
What You’ll Learn
- The benefits and potential challenges of transitioning to a prefilled syringe
- How to select the right syringe components and evaluate formulation compatibility
- Key considerations for fill volume, stability testing, and container closure integrity testing (CCIT)
- A step-by-step guide to prefilled syringe tech transfer, including recommended stability studies and timelines
- How to plan for autoinjector compatibility and future commercial manufacturing
Who Should Read This
This whitepaper was written for drug developers considering a transition from vials to prefilled syringes, sponsors preparing for clinical or commercial manufacturing, and teams evaluating container closure systems, stability requirements, or fill-finish CDMO partners.
